Stockscreener 앱 받기
3.37
13.14%
-0.51
시장 영업 전:
3.34
-0.03
-0.89%
908 Devices Inc 주식(MASS)의 최신 뉴스
Stifel maintains Buy on 908 Devices, target steady at $6 By Investing.com - Investing.com Canada
Stifel maintains Buy on 908 Devices, target steady at $6 - Investing.com India
Repligen lays down $70m to buy analytics tech from 908 Devices - BioProcess Insider
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices - Genetic Engineering & Biotechnology News
908 Devices Inc.'s (NASDAQ:MASS) 55% Jump Shows Its Popularity With Investors - Simply Wall St
908 Devices Inc (MASS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - Yahoo Finance
908 Devices Inc. Reports Strategic Transformation and Growth - TipRanks
908 Devices stock surges on strategic transformation and growth outlook By Investing.com - Investing.com South Africa
908 Devices stock surges on strategic transformation and growth outlook - Investing.com India
Repligen Corporation acquired the assets related to bioprocessing analytics portfolio of 908 Devices Inc. for $56 million. - Marketscreener.com
908 Devices jumps as Repligen buys bioprocessing analytics portfolio - MSN
Earnings call transcript: 908 Devices Q4 2024 revenue up 31%, stock surges - Investing.com India
MASS’s 2023 Market Dance: Up 66.78% – Time to Invest? - The InvestChronicle
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth - Benzinga
Strategic Divestment and Focus on Growth Propel 908 Devices to a Buy Rating - TipRanks
908 Devices earnings missed by $0.33, revenue fell short of estimates - Investing.com
908 Devices reports Q4 EPS (56c), consensus (35c) - TipRanks
908 Devices Inc. reports results for the quarter ended December 31Earnings Summary - TradingView
Repligen Corporation acquired Bioprocessing Analytics Portfolio from 908 Devices Inc. for $70 million. - Marketscreener.com
Repligen’s Strategic Acquisition of 908 Devices’ Bioprocessing Assets Boosts Buy Rating - TipRanks
MASSive Gains for 908 Devices: Is This Stock Turning Around? - RagingBull
908 Devices Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
Investor presentation (03/04/2025 00: 00 - Marketscreener.com
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Repligen Acquires 908 Devices’ Bioprocess Analytics Portfolio - Contract Pharma
908 DEVICES Earnings Results: $MASS Reports Quarterly Earnings - Nasdaq
908 Devices stock jumps on Repligen deal (RGEN:NASDAQ) - Seeking Alpha
Repligen acquires 908 Devices’ desktop bioprocessing tech - Investing.com India
908 Devices stock soars on divestiture and revenue growth - Investing.com
Repligen Buys 908 Devices' Desktop Portfolio for $70 Million -March 04, 2025 at 08:07 am EST - Marketscreener.com
908 Devices Announces Strategic Transformation and Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
908 Devices sells desktop assets, sees revenue growth - Investing.com
BRIEF-908 Devices Q4 EPS USD -0.56 - TradingView
Repligen purchases 908 Devices’ bioprocessng analytics portfolio for $70M - TipRanks
How Will 908 Devices' $70M Portfolio Sale to Repligen Reshape Its Business Strategy? - StockTitan
908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - BioSpace
908 Devices to Participate in Upcoming Investor Conferences - 01Net
Want to Hear From 908 Devices Leadership? Two Major Healthcare Conferences Coming Up - StockTitan
908 Devices (MASS) Projected to Post Quarterly Earnings on Tuesday - Defense World
ARK Investment Management LLC Has $6.14 Million Stock Position in 908 Devices Inc. (NASDAQ:MASS) - MarketBeat
908 Devices' chief product officer sells $18,190 in stock - MSN
908 Devices (MASS) to Release Quarterly Earnings on Tuesday - MarketBeat
908 devices CEO Kevin J. Knopp sells $37,109 in stock - MSN
10 Biotech Companies in Germany to Know - Built In
908 Devices (NASDAQ:MASS) Given Sell (E+) Rating at Weiss Ratings - Defense World
908 Devices Inc. (NASDAQ:MASS) Shares Sold by Sumitomo Mitsui Trust Group Inc. - Defense World
Insider Selling: 908 Devices Inc. (NASDAQ:MASS) Insider Sells 9,672 Shares of Stock - MarketBeat
908 Devices' (MASS) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
February 2025 US Penny Stocks To Watch - Simply Wall St
908 Devices Inc. (NASDAQ:MASS) CFO Sells $23,952.24 in Stock - MarketBeat
0.73%
0.56%
자본화:
|
볼륨(24시간):